Abstract
Unlike other potential targets of future stem cell approaches, there is already a current cell therapy for the treatment of type I diabetes. Indeed, islet transplantation has proven successful in inducing insulin independence for at least 1 year after the procedure. Progress in this discipline during the past 20 years has paved the way for stem cell-based therapies. Here we review the current state of the art of islet transplantation and examine the challenges that need to be addressed before a transition is made to stem cell-derived insulin-producing cells, with particular emphasis on the immunological aspects (rejection and autoimmunity) of type I diabetes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S. & Jones, J.M. Embryonic stem cell lines derived from human blastocysts. Science. 282, 1145–7 (1998).
Merani, S. & Shapiro, A.M. Current status of pancreatic islet transplantation. Clin Sci (Lond). 110, 611–25 (2006).
Ricordi, C. & Strom, T.B. Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol. 4, 259–68 (2004).
Shapiro, A.M., Lakey, J.R., Ryan, E.A., Korbutt, G.S., Toth, E., Warnock, G.L., Kneteman, N.M. & Rajotte, R.V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 343, 230–8 (2000).
Poggioli, R., Faradji, R.N., Ponte, G., Betancourt, A., Messinger, S., Baidal, D.A., Froud, T., Ricordi, C. & Alejandro, R. Quality of life after islet transplantation. Am J Transplant. 6, 371–8 (2006).
Moritz, W., Meier, F., Stroka, D.M., Giuliani, M., Kugelmeier, P., Nett, P.C., Lehmann, R., Candinas, D., Gassmann, M. & Weber, M. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. FASEB J. 16, 745–7 (2002).
Butler, P.C., Meier, J.J., Butler, A.E. & Bhushan, A. The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab. 3, 758–68 (2007).
Matsumoto, S., Okitsu, T., Iwanaga, Y., Noguchi, H., Nagata, H., Yonekawa, Y., Liu, X., Kamiya, H., Ueda, M., Hatanaka, N., Kobayashi, N., Yamada, Y., Miyakawa, S., Seino, Y., Shapiro, A.M. & Tanaka, K. Follow-up study of the first successful living donor islet transplantation. Transplantation. 82, 1629–33 (2006).
Matsumoto, S., Okitsu, T., Iwanaga, Y., Noguchi, H., Nagata, H., Yonekawa, Y., Yamada, Y., Nakai, Y., Ueda, M., Ishii, A., Yabunaka, E., Shapiro, J.A. & Tanaka, K. Insulin independence of unstable diabetic patient after single living donor islet transplantation. Transplant Proc. 37, 3427–9 (2005).
Pasquali, L., Fan, Y., Trucco, M. & Ringquist, S. Rehabilitation of adaptive immunity and regeneration of beta cells. Trends Biotechnol. 24, 516–22 (2006).
Pasquali, L., Giannoukakis, N. & Trucco, M. Induction of immune tolerance to facilitate beta cell regeneration in type 1 diabetes. Adv Drug Deliv Rev. 60, 106–13 (2008).
Martin-Pagola, A., Sisino, G., Allende, G., Dominguez-Bendala, J., Gianani, R., Reijonen, H., Nepom, G.T., Ricordi, C., Ruiz, P., Sageshima, J., Ciancio, G., Burke, G.W. & Pugliese, A. Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity. Diabetologia. 51, 1803–13 (2008).
Pastori, R.L., Klein, D., Ribeiro, M.M. & Ricordi, C. Delivery of proteins and peptides into live cells by means of protein transduction domains: potential application to organ and cell transplantation. Transplantation. 77, 1627–31 (2004).
Embury, J., Klein, D., Pileggi, A., Ribeiro, M., Jayaraman, S., Molano, R.D., Fraker, C., Kenyon, N., Ricordi, C., Inverardi, L. & Pastori, R.L. Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. Diabetes. 50, 1706–13 (2001).
Klein, D., Mendoza, V., Pileggi, A., Molano, R.D., Barbe-Tuana, F.M., Inverardi, L., Ricordi, C. & Pastori, R.L. Delivery of TAT/PTD-fused proteins/peptides to islets via pancreatic duct. Cell Transplant. 14, 241–8 (2005).
Mendoza, V., Klein, D., Ichii, H., Ribeiro, M.M., Ricordi, C., Hankeln, T., Burmester, T. & Pastori, R.L. Protection of islets in culture by delivery of oxygen binding neuroglobin via protein transduction. Transplant Proc. 37, 237–40 (2005).
Ribeiro, M.M., Klein, D., Pileggi, A., Molano, R.D., Fraker, C., Ricordi, C., Inverardi, L. & Pastori, R.L. Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic beta-cells. Biochem Biophys Res Commun. 305, 876–81 (2003).
Klein, D., Ribeiro, M.M., Mendoza, V., Jayaraman, S., Kenyon, N.S., Pileggi, A., Molano, R.D., Inverardi, L., Ricordi, C. & Pastori, R.L. Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets. Biochem Biophys Res Commun. 323, 473–8 (2004).
Varona-Santos, J.L., Pileggi, A., Molano, R.D., Sanabria, N.Y., Ijaz, A., Atsushi, M., Ichii, H., Pastori, R.L., Inverardi, L., Ricordi, C. & Fornoni, A. c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets. Diabetologia. 51, 2271–80 (2008).
Ijaz, A., Tejada, T., Catanuto, P., Xia, X., Elliot, S.J., Lenz, O., Jauregui, A., Saenz, M.O., Molano, R.D., Pileggi, A., Ricordi, C. & Fornoni, A. Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes. Kidney Int. 75(4), 381–8 (2009).
Pileggi, A., Molano, R.D., Berney, T., Cattan, P., Vizzardelli, C., Oliver, R., Fraker, C., Ricordi, C., Pastori, R.L., Bach, F.H. & Inverardi, L. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes. 50, 1983–91 (2001).
Papas, K.K., Avgoustiniatos, E.S., Tempelman, L.A., Weir, G.C., Colton, C.K., Pisania, A., Rappel, M.J., Friberg, A.S., Bauer, A.C. & Hering, B.J. High-density culture of human islets on top of silicone rubber membranes. Transplant Proc. 37, 3412–4 (2005).
London, N.J., Swift, S.M. & Clayton, H.A. Isolation, culture and functional evaluation of islets of Langerhans. Diabetes Metab. 24, 200–7 (1998).
Murdoch, T.B., McGhee-Wilson, D., Shapiro, A.M. & Lakey, J.R. Methods of human islet culture for transplantation. Cell Transplant. 13, 605–17 (2004).
Speier, S., Nyqvist, D., Cabrera, O., Yu, J., Molano, R.D., Pileggi, A., Moede, T., Kohler, M., Wilbertz, J., Leibiger, B., Ricordi, C., Leibiger, I.B., Caicedo, A. & Berggren, P.O. Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med. 14(5), 574–8 (2008).
Abdi, R., Fiorina, P., Adra, C.N., Atkinson, M. & Sayegh, M.H. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 57, 1759–67 (2008).
Ozaki, K., Sato, K., Oh, I., Meguro, A., Tatara, R., Muroi, K. & Ozawa, K. Mechanisms of immunomodulation by mesenchymal stem cells. Int J Hematol. 86, 5–7 (2007).
Xu, Y.X., Chen, L., Wang, R., Hou, W.K., Lin, P., Sun, L., Sun, Y. & Dong, Q.Y. Mesenchymal stem cell therapy for diabetes through paracrine mechanisms. Med Hypotheses. 71, 390–3 (2008).
Sadat, S., Gehmert, S., Song, Y.H., Yen, Y., Bai, X., Gaiser, S., Klein, H. & Alt, E. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun. 363, 674–9 (2007).
Burt, R.K., Cohen, B., Rose, J., Petersen, F., Oyama, Y., Stefoski, D., Katsamakis, G., Carrier, E., Kozak, T., Muraro, P.A., Martin, R., Hintzen, R., Slavin, S., Karussis, D., Haggiag, S., Voltarelli, J.C., Ellison, G.W., Jovanovic, B., Popat, U., McGuirk, J., Statkute, L., Verda, L., Haas, J. & Arnold, R. Hematopoietic stem cell transplantation for multiple sclerosis. Arch Neurol. 62, 860–4 (2005).
Voltarelli, J.C., Couri, C.E., Stracieri, A.B., Oliveira, M.C., Moraes, D.A., Pieroni, F., Coutinho, M., Malmegrim, K.C., Foss-Freitas, M.C., Simoes, B.P., Foss, M.C., Squiers, E. & Burt, R.K. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 297, 1568–76 (2007).
Chaudhary, S.B., Liporace, F.A., Gandhi, A., Donley, B.G., Pinzur, M.S. & Lin, S.S. Complications of ankle fracture in patients with diabetes. J Am Acad Orthop Surg. 16, 159–70 (2008).
Watkinson, S. & Seewoodhary, R. Ocular complications associated with diabetes mellitus. Nurs Stand. 22, 51–7; quiz 58, 60 (2008).
Ricordi, C. Islet transplantation: a brave new world. Diabetes. 52, 1595–603 (2003).
Burke, G.W., Ciancio, G. & Sollinger, H.W. Advances in pancreas transplantation. Transplantation. 77, S62–7 (2004).
Pirsch, J.D., Andrews, C., Hricik, D.E., Josephson, M.A., Leichtman, A.B., Lu, C.Y., Melton, L.B., Rao, V.K., Riggio, R.R., Stratta, R.J. & Weir, M.R. Pancreas transplantation for diabetes mellitus. Am J Kidney Dis. 27, 444–50 (1996).
Inverardi, L., Kenyon, N.S. & Ricordi, C. Islet transplantation: immunological perspectives. Curr Opin Immunol. 15, 507–11 (2003).
Pileggi, A., Alejandro, R. & Ricordi, C. Clinical islet transplantation. Minerva Endocrinol. 31, 219–32 (2006).
Seung, E., Mordes, J.P., Greiner, D.L. & Rossini, A.A. Induction of tolerance for islet transplantation for type 1 diabetes. Curr Diab Rep. 3, 329–35 (2003).
Iwanaga, Y., Matsumoto, S., Okitsu, T., Noguchi, H., Nagata, H., Yonekawa, Y., Yamada, Y., Fukuda, K., Tsukiyama, K. & Tanaka, K. Living donor islet transplantation, the alternative approach to overcome the obstacles limiting transplant. Ann NY Acad Sci. 1079, 335–9 (2006).
Jung, H.S., Choi, S.H., Kim, S.J., Lee, K.T., Lee, J.K., Jang, K.T., Lee, B.W., Jee, J.H., Oh, S.H., Ahn, Y.R., Lee, M.K. & Kim, K.W. A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors. Clin Transplant. 21, 738–43 (2007).
Ricordi, C., Lacy, P.E., Finke, E.H., Olack, B.J. & Scharp, D.W. Automated method for isolation of human pancreatic islets. Diabetes. 37, 413–20 (1988).
Sakuma, Y., Ricordi, C., Miki, A., Yamamoto, T., Pileggi, A., Khan, A., Alejandro, R., Inverardi, L. & Ichii, H. Factors that affect human islet isolation. Transplant Proc. 40, 343–5 (2008).
Froud, T., Ricordi, C., Baidal, D.A., Hafiz, M.M., Ponte, G., Cure, P., Pileggi, A., Poggioli, R., Ichii, H., Khan, A., Ferreira, J.V., Pugliese, A., Esquenazi, V.V., Kenyon, N.S. & Alejandro, R. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant. 5, 2037–46 (2005).
Markmann, J.F., Deng, S., Huang, X., Desai, N.M., Velidedeoglu, E.H., Lui, C., Frank, A., Markmann, E., Palanjian, M., Brayman, K., Wolf, B., Bell, E., Vitamaniuk, M., Doliba, N., Matschinsky, F., Barker, C.F. & Naji, A. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg. 237, 741–9; discussion 749–50 (2003).
Barshes, N.R., Wyllie, S. & Goss, J.A. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol. 77, 587–97 (2005).
Johansson, H., Lukinius, A., Moberg, L., Lundgren, T., Berne, C., Foss, A., Felldin, M., Kallen, R., Salmela, K., Tibell, A., Tufveson, G., Ekdahl, K.N., Elgue, G., Korsgren, O. & Nilsson, B. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes. 54, 1755–62 (2005).
Moberg, L., Johansson, H., Lukinius, A., Berne, C., Foss, A., Kallen, R., Ostraat, O., Salmela, K., Tibell, A., Tufveson, G., Elgue, G., Nilsson Ekdahl, K., Korsgren, O. & Nilsson, B. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet. 360, 2039–45 (2002).
Cobianchi, L., Fornoni, A., Pileggi, A., Molano, R.D., Sanabria, N.Y., Gonzalez-Quintana, J., Bocca, N., Marzorati, S., Zahr, E., Hogan, A.R., Ricordi, C. & Inverardi, L. Riboflavin inhibits IL-6 expression and p38 activation in islet cells. Cell Transplant. 17, 559–66 (2008).
Yamamoto, T., Ricordi, C., Mita, A., Miki, A., Sakuma, Y., Molano, R.D., Fornoni, A., Pileggi, A., Inverardi, L. & Ichii, H. Beta-cell specific cytoprotection by prolactin on human islets. Transplant Proc. 40, 382–3 (2008).
McCabe, C. & O’Brien, T. The rational design of beta cell cytoprotective gene transfer strategies: targeting deleterious iNOS expression. Mol Biotechnol. 37, 38–47 (2007).
Kapturczak, M.H., Flotte, T. & Atkinson, M.A. Adeno-associated virus (AAV) as a vehicle for therapeutic gene delivery: improvements in vector design and viral production enhance potential to prolong graft survival in pancreatic islet cell transplantation for the reversal of type 1 diabetes. Curr Mol Med. 1, 245–58 (2001).
Truong, W., Hancock, W.W., Anderson, C.C., Merani, S. & Shapiro, A.M. Coinhibitory T-cell signaling in islet allograft rejection and tolerance. Cell Transplant. 15, 105–19 (2006).
Delovitch, T.L. & Singh, B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity. 7, 727–38 (1997).
Makino, S., Kunimoto, K., Muraoka, Y., Mizushima, Y., Katagiri, K. & Tochino, Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 29, 1–13 (1980).
Anand, S. & Chen, L. Control of autoimmune diseases by the B7-CD28 family molecules. Curr Pharm Des. 10, 121–8 (2004).
Chen, L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol. 4, 336–47 (2004).
Salomon, B., Lenschow, D.J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A. & Bluestone, J.A. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12, 431–40 (2000).
Balasa, B., Krahl, T., Patstone, G., Lee, J., Tisch, R., McDevitt, H.O. & Sarvetnick, N. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol. 159, 4620–7 (1997).
Lenschow, D.J., Ho, S.C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K.C. & Bluestone, J.A. Differential effects of anti-B7–1 and anti-B7–2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med. 181, 1145–55 (1995).
Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol. 4, 330–6 (2003).
Good, R.A. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases. World J Surg. 24, 797–810 (2000).
Inverardi, L., Linetsky, E., Pileggi, A., Molano, R.D., Serafini, A., Paganelli, G. & Ricordi, C. Targeted bone marrow radioablation with 153Samarium-lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness. Transplantation. 77, 647–55 (2004).
Li, H., Inverardi, L., Molano, R.D., Pileggi, A. & Ricordi, C. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts. Transplantation. 75, 966–70 (2003).
Mineo, D., Ricordi, C., Xu, X., Pileggi, A., Garcia-Morales, R., Khan, A., Baidal, D.A., Han, D., Monroy, K., Miller, J., Pugliese, A., Froud, T., Inverardi, L., Kenyon, N.S. & Alejandro, R. Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance. Am J Transplant. 8, 1262–74 (2008).
Neto, A.B., DeFaria, W., Berho, M., Carreno, M., Misiakos, E.P., Ruiz, P., Inverardi, L., Ricart, F., Tsinari, K., Miller, J., Ricordi, C. & Tzakis, A.G. Mixed allogeneic chimerism by combined use of nonlethal radiation and antilymphocyte serum in a rat small bowel transplantation model. Transplant Proc. 32, 1311–2 (2000).
Han, D., Ricordi, C. & Kenyon, N.S. Establishment of a method for analysis of chimerism in a baboon model (Papio hamadryas) of islet/bone marrow transplantation. Transplant Proc. 30, 554–5 (1998).
Bakonyi, A., Berho, M., Ruiz, P., Misiakos, E.P., Carreno, M., de Faria, W., Sommariva, A., Inverardi, L., Miller, J., Ricordi, C. & Tzakis, A.G. Donor and recipient pretransplant conditioning with nonlethal radiation and antilymphocyte serum improves the graft survival in a rat small bowel transplant model. Transplantation. 72, 983–8 (2001).
Sharabi, Y., Abraham, V.S., Sykes, M. & Sachs, D.H. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant. 9, 191–7 (1992).
Sharabi, Y. & Sachs, D.H. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med. 169, 493–502 (1989).
Sykes, M., Sharabi, Y. & Sachs, D.H. Achieving alloengraftment without graft-versus-host disease: approaches using mixed allogeneic bone marrow transplantation. Bone Marrow Transplant. 3, 379–86 (1988).
Orive, G., Bartkowiak, A., Lisiecki, S., De Castro, M., Hernandez, R.M., Gascon, A.R. & Pedraz, J.L. Biocompatible oligochitosans as cationic modifiers of alginate/Ca microcapsules. J Biomed Mater Res B Appl Biomater. 74, 429–39 (2005).
Orive, G., Ponce, S., Hernandez, R.M., Gascon, A.R., Igartua, M. & Pedraz, J.L. Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates. Biomaterials. 23, 3825–31 (2002).
Korbutt, G.S., Mallett, A.G., Ao, Z., Flashner, M. & Rajotte, R.V. Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation. Diabetologia. 47, 1810–8 (2004).
Beck, J., Angus, R., Madsen, B., Britt, D., Vernon, B. & Nguyen, K.T. Islet encapsulation: strategies to enhance islet cell functions. Tissue Eng. 13, 589–99 (2007).
Lanza, R.P., Lodge, P., Borland, K.M., Carretta, M., Sullivan, S.J., Beyer, A.M., Muller, T.E., Solomon, B.A., Maki, T., Monaco, A.P. et al. Transplantation of islet allografts using a diffusion-based biohybrid artificial pancreas: long-term studies in diabetic, pancreatectomized dogs. Transplant Proc. 25, 978–80 (1993).
Sullivan, S.J., Maki, T., Carretta, M., Ozato, H., Borland, K., Mahoney, M.D., Muller, T.E., Solomon, B.A., Monaco, A.P. & Chick, W.L. Evaluation of the hybrid artificial pancreas in diabetic dogs. ASAIO J. 38, 29–33 (1992).
Petersen, P., Lembert, N., Zschocke, P., Stenglein, S., Planck, H., Ammon, H.P. & Becker, H.D. Hydroxymethylated polysulphone for islet macroencapsulation allows rapid diffusion of insulin but retains PERV. Transplant Proc. 34, 194–5 (2002).
Wang, W., Upshaw, L., Strong, D.M., Robertson, R.P. & Reems, J. Increased oxygen consumption rates in response to high glucose detected by a novel oxygen biosensor system in non-human primate and human islets. J Endocrinol. 185, 445–55 (2005).
Krol, S., del Guerra, S., Grupillo, M., Diaspro, A., Gliozzi, A. & Marchetti, P. Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets. Nano Lett. 6, 1933–9 (2006).
Nolan, K., Millet, Y., Ricordi, C. & Stabler, C.L. Tissue engineering and biomaterials in regenerative medicine. Cell Transplant. 17, 241–3 (2008).
Pileggi, A., Molano, R.D., Ricordi, C., Zahr, E., Collins, J., Valdes, R. & Inverardi, L. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation. 81, 1318–24 (2006).
Soulillou, J.P. & Giral, M. Controlling the incidence of infection and malignancy by modifying immunosuppression. Transplantation. 72, S89–93 (2001).
Li, L., Baroja, M.L., Majumdar, A., Chadwick, K., Rouleau, A., Gallacher, L., Ferber, I., Lebkowski, J., Martin, T., Madrenas, J. & Bhatia, M. Human embryonic stem cells possess immune-privileged properties. Stem Cells. 22, 448–56 (2004).
Lin, G., OuYang, Q., Zhou, X., Gu, Y., Yuan, D., Li, W., Liu, G., Liu, T. & Lu, G. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure. Cell Res. 17, 999–1007 (2007).
Revazova, E.S., Turovets, N.A., Kochetkova, O.D., Agapova, L.S., Sebastian, J.L., Pryzhkova, M.V., Smolnikova, V.I., Kuzmichev, L.N. & Janus, J.D. HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells. 10, 11–24 (2008).
Brevini, T.A. & Gandolfi, F. Parthenotes as a source of embryonic stem cells. Cell Prolif. 41(Suppl 1), 20–30 (2008).
Wasserman, D. What qualifies as a live embryo? Am J Bioeth. 5, 23–5; discussion W10–3 (2005).
Prigozhina, T.B., Khitrin, S., Elkin, G., Eizik, O., Morecki, S. & Slavin, S. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation. Exp Hematol. 36, 1370–6 (2008).
Meier, J.J., Bhushan, A., Butler, A.E., Rizza, R.A. & Butler, P.C. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia. 48, 2221–8 (2005).
Meier, J.J., Lin, J.C., Butler, A.E., Galasso, R., Martinez, D.S. & Butler, P.C. Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia. 49, 1838–44 (2006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Domínguez-Bendala, J. (2009). Remaining Challenges and Clinical Perspectives. In: Pancreatic Stem Cells. Stem Cell Biology and Regenerative Medicine. Humana Press. https://doi.org/10.1007/978-1-60761-132-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-60761-132-5_8
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-131-8
Online ISBN: 978-1-60761-132-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)